Drug intelligence / Profile preview

Liujing Toutong Pian

Development stage: Unknown
Lead developer: Tianjin Pharmaceutical Da Ren Tang Group
Modality: Small Molecules
Administration: Oral

Overview

Liujing Toutong Pian is a traditional Chinese medicine (TCM) oral tablet developed and manufactured by Tianjin Pharmaceutical Da Ren Tang. It is indicated for the symptomatic relief of various types of headaches, including those categorized under the 'Six Meridians' theory of TCM (such as wind-cold or wind-heat headaches). The formulation is a complex mixture of traditional herbs, commonly including *Ligusticum chuanxiong* (Chuanxiong) and *Angelica dahurica* (Baizhi), which are recognized in TCM for their analgesic and 'wind-dispelling' properties. It is an approved pharmaceutical product in China, used to treat both acute and chronic headache conditions.

Brand names: 六经头痛片Liujing Toutong Pian
Other names: Liujing Toutong Tablets

Beyond the preview

Go deeper on Liujing Toutong Pian.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liujing Toutong Pian.

Explore the full profile